GLP-1S NewsLatest News On GLP-1S FDA Approves Ozempic for Chronic Kidney Disease and Diabetes1/28/2025 5:27 PM GLP-1s Are Popular Obesity Meds, But What Role Could Prevention Play In Revamped HHS?12/1/2024 10:42 AM Women Taking Mounjaro And Zepbound Lose More Weight Than Men, New Study Suggests: What To Know9/11/2024 5:40 PM Women Taking Mounjaro And Zepbound Lose More Weight Than Men, New Study Suggests: What To Know9/11/2024 4:18 PM Beyond The Sticker Shock: Why GLP-1s Might Save More Than They Cost9/3/2024 6:01 AM GLP-1 Shortages Raise Questions About Prioritizing Access For Diabetics7/19/2024 6:17 AM GLP-1 Shortages Raise Questions About Prioritizing Access For Diabetics7/19/2024 6:17 AM Study Shows 85% Of Patients Discontinue GLP-1s For Weight Loss After 2 Years7/11/2024 5:53 PM European Union Regulators Find No Evidence of Increased Suicide Risk in Popular Weight Loss and Diabetes Drugs4/12/2024 8:23 AM Danone CEO downplays threat of obesity drugs on food business4/4/2024 5:01 AM Danone CEO downplays threat of obesity drugs on food business4/4/2024 5:01 AM
